BLOG / 🇺🇸 United States · · daily

High-Value Federal Grants ($5M+) — May 13, 2026

High-Value Federal Grants ($5M+)

By Gunpowder Editorial ·

6 total filings analysed

Executive Summary

This digest covers $4,176,750,195 in high-value federal grants ($5M+) awarded or obligated in the May 13, 2026 period, with 0/6 defense-related and all civilian agency focus across DHS, HHS, VA, and USAID. Dominant themes include large-scale construction (DHS to Southwest Valley Constructors Co $1.72B), biotech preparedness (HHS to Bavarian Nordic A/S $1.26B and Albert B.

Sabin Vaccine Institute $310M combined), and IT services (VA to Booz Allen Hamilton Inc $810M). Highest-conviction bullish signals stem from the top three high-materiality awards ($3.79B total), signaling multi-year revenue stability for recipients amid full funding commitments. Key risk is uneven outlay pacing, with Booz Allen at $318M (39%) outlayed on its $810M award and Sabin contracts showing 38-60% progress, warranting monitoring for cash flow implications.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Tracking the trend? Catch up on the prior High-Value Federal Grants ($5M+) digest from May 10, 2026.

Investment Signals (4)

  • Southwest Valley Constructors Co Secures $1.72B DHS Grant (HIGH)

    Southwest Valley Constructors Co received a $1,720,040,000 grant from DHS on 2026-05-11, a high-materiality bullish signal for construction revenue in homeland security infrastructure.

  • Bavarian Nordic A/S Wins $1.26B HHS Biotech Grant (HIGH)

    Bavarian Nordic A/S was awarded a $1,264,240,981 grant from HHS on 2017-08-24, providing long-term bullish revenue visibility in vaccine/biotech development.

  • Booz Allen Hamilton Inc Lands $810M VA IT Services Delivery Order (HIGH)

    Booz Allen Hamilton Inc secured a $809,754,946 time-and-materials delivery order from VA on 2019-05-17 under full and open competition, with $317,898,571 (39%) outlayed to date supporting steady ~$140-145M annual revenue through 2025-01-22.

  • Albert B. Sabin Vaccine Institute Receives $310M Combined HHS Grants (MEDIUM)

    Albert B. Sabin Vaccine Institute, Inc. holds two HHS grants totaling $310,144,424 ($163M on 2022-12-29 and $147M on 2019-09-26) for ebolavirus vaccine R&D through 2030, with $150M combined outlayed but neutral due to nonprofit status limiting equity upside.

Risk Flags (3)

  • Execution [MEDIUM RISK]

    Uneven outlay pacing on Booz Allen Hamilton Inc's $809.8M VA IT contract, with only $317.9M (39%) outlayed as of data cutoff despite 5+ year term to 2025-01-22.

  • Budget [HIGH RISK]

    High pricing risk on Nelson Environmental Remediation USA Ltd's $72.6M USAID firm-fixed-price grant for dioxin remediation, with only $10.7M (15%) outlayed early in 6.6-year term to 2029-06-29.

  • Concentration [MEDIUM RISK]

    Nonprofit status of Albert B. Sabin Vaccine Institute eliminates direct equity investment in $310M HHS grants, despite stable BARDA funding for vaccine R&D.

Opportunities (3)

  • Booz Allen Hamilton Inc poised for remaining $492M outlays on $810M VA IT services grant through 2025-01-22.

  • Albert B. Sabin Vaccine Institute option expansions on HHS grants, from $163M to $241M ceiling and $147M to $150M.

  • Nelson Environmental Remediation USA Ltd's $72.6M USAID remediation grant offers ~$11M annual revenue potential over 6.6 years for small disadvantaged business.

Sector Themes (2)

  • HHS awarded $1.26B to Bavarian Nordic A/S and $310M combined to Albert B. Sabin Vaccine Institute for ebolavirus and related vaccine R&D/manufacturing through 2030, with $150M+ outlayed under cost-plus contracts.

  • VA's $810M time-and-materials delivery order to Booz Allen Hamilton Inc for IT operations transformation, fully committed with $318M outlayed via full/open competition.

Watch List (3)

  • 👁

    {"entity"=>"Booz Allen Hamilton Inc (BAH)", "reason"=>"$809.8M VA IT grant with $317.9M outlayed (39%); steady revenue but pacing risk to 2025-01-22.", "trigger"=>"outlay progress beyond $317.9M; modifications to end date"}

  • 👁

    {"entity"=>"Albert B. Sabin Vaccine Institute, Inc.", "reason"=>"Combined $310M HHS grants with $150M outlayed; options could add $92M+ through 2030.", "trigger"=>"option exercise on $163M (to $241M) and $147M (to $150M) awards"}

  • 👁

    {"entity"=>"Nelson Environmental Remediation USA Ltd", "reason"=>"$72.6M USAID firm-fixed-price grant with only $10.7M (15%) outlayed early in term to 2029-06-29.", "trigger"=>"outlay acceleration; contract modifications"}

Get daily alerts with 4 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 6 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: High-Value Federal Grants ($5M+)

🇺🇸 More from United States

View all →